Jon A. Weidanz Experimmune, A Center for Immunotherapeutic Development, Department of Immunotherapeutics and Biotechnology Texas Tech University Health Sciences Center Biography Publications Institution JoVE Articles Jon A. Weidanz has not added a biography. If you are Jon A. Weidanz and would like to personalize this page please email our Author Liaison for assistance. Publications A Novel T-cell Receptor Mimic Defines Dendritic Cells That Present an Immunodominant West Nile Virus Epitope in Mice European Journal of Immunology. Jul, 2014 | Pubmed ID: 24723377 Antitumor Activity of a Monoclonal Antibody Targeting Major Histocompatibility Complex Class I-Her2 Peptide Complexes Journal of the National Cancer Institute. Feb, 2013 | Pubmed ID: 23300219 TCR-like Biomolecules Target Peptide/MHC Class I Complexes on the Surface of Infected and Cancerous Cells International Reviews of Immunology. Oct-Dec, 2011 | Pubmed ID: 22053972 Expanding the Targets Available to Therapeutic Antibodies Via Novel Disease-specific Markers International Reviews of Immunology. Oct-Dec, 2011 | Pubmed ID: 22053971 TCR Mimic Monoclonal Antibodies Induce Apoptosis of Tumor Cells Via Immune Effector-independent Mechanisms Journal of Immunology (Baltimore, Md. : 1950). Mar, 2011 | Pubmed ID: 21282517 A Novel Vascular Targeting Strategy for Brain-derived Endothelial Cells Using a TCR Mimic Antibody Journal of Cellular Physiology. Nov, 2010 | Pubmed ID: 20506235 Single-chain HLA-A2 MHC Trimers That Incorporate an Immundominant Peptide Elicit Protective T Cell Immunity Against Lethal West Nile Virus Infection Journal of Immunology (Baltimore, Md. : 1950). Apr, 2010 | Pubmed ID: 20212098 TCR Mimic Monoclonal Antibody Targets a Specific Peptide/HLA Class I Complex and Significantly Impedes Tumor Growth in Vivo Using Breast Cancer Models Journal of Immunology (Baltimore, Md. : 1950). Feb, 2010 | Pubmed ID: 20065111 Direct Discovery and Validation of a Peptide/MHC Epitope Expressed in Primary Human Breast Cancer Cells Using a TCRm Monoclonal Antibody with Profound Antitumor Properties Cancer Immunology, Immunotherapy : CII. Apr, 2010 | Pubmed ID: 19779714 Aspirin Inhibits Camptothecin-induced P21CIP1 Levels and Potentiates Apoptosis in Human Breast Cancer Cells International Journal of Oncology. Mar, 2009 | Pubmed ID: 19212664 RAAV/Her-2/neu Loading of Dendritic Cells for a Potent Cellular-mediated MHC Class I Restricted Immune Response Against Ovarian Cancer Viral Immunology. Dec, 2008 | Pubmed ID: 19115932 Sperm Protein 17 is a Suitable Target for Adoptive T-cell-based Immunotherapy in Human Ovarian Cancer Journal of Immunotherapy (Hagerstown, Md. : 1997). Oct, 2008 | Pubmed ID: 18779750 Assessing Vaccine Potency Using TCRmimic Antibodies Vaccine. Jun, 2008 | Pubmed ID: 18353510 Identification of Breast Cancer Peptide Epitopes Presented by HLA-A*0201 Journal of Proteome Research. Apr, 2008 | Pubmed ID: 18345606 A NOD/SCID Tumor Model for Human Ovarian Cancer That Allows Tracking of Tumor Progression Through the Biomarker Sp17 Journal of Immunological Methods. Apr, 2007 | Pubmed ID: 17336323 Development and Implementation of a Direct Detection, Quantitation and Validation System for Class I MHC Self-peptide Epitopes Journal of Immunological Methods. Jan, 2007 | Pubmed ID: 17134715 Levels of Specific Peptide-HLA Class I Complex Predicts Tumor Cell Susceptibility to CTL Killing Journal of Immunology (Baltimore, Md. : 1950). Oct, 2006 | Pubmed ID: 17015692 Antibody Targeting to a Class I MHC-peptide Epitope Promotes Tumor Cell Death Journal of Immunology (Baltimore, Md. : 1950). Sep, 2006 | Pubmed ID: 16951384 Attenuation of Acute Rejection in a Rat Liver Transplantation Model by a Liver-targeted Dextran Prodrug of Methylprednisolone Transplantation. Mar, 2006 | Pubmed ID: 16534468 ATR Blockade Reduces IFN-gamma Production in Lymphocytes in Vivo and in Vitro Kidney International. Jun, 2005 | Pubmed ID: 15882256 Testing Recombinant Adeno-associated Virus-gene Loading of Dendritic Cells for Generating Potent Cytotoxic T Lymphocytes Against a Prototype Self-antigen, Multiple Myeloma HM1.24 Blood. Nov, 2003 | Pubmed ID: 12855576 Påvisning av humant leukocytt antigen Biomarkører i Breast Cancer Utnytte Etikett-free Biosensor Technology Jon A. Weidanz1, Krysten L. Doll1, Soumya Mohana-Sundaram1, Timea Wichner1, Devin B. Lowe1, Susanne Gimlin2, Debra Wawro Weidanz2, Robert Magnusson2,3, Oriana E. Hawkins1 1Experimmune, A Center for Immunotherapeutic Development, Department of Immunotherapeutics and Biotechnology, Texas Tech University Health Sciences Center, 2Resonant Sensors Incorporated, 3University of Texas Arlington JoVE 52159 Immunology and Infection
Påvisning av humant leukocytt antigen Biomarkører i Breast Cancer Utnytte Etikett-free Biosensor Technology Jon A. Weidanz1, Krysten L. Doll1, Soumya Mohana-Sundaram1, Timea Wichner1, Devin B. Lowe1, Susanne Gimlin2, Debra Wawro Weidanz2, Robert Magnusson2,3, Oriana E. Hawkins1 1Experimmune, A Center for Immunotherapeutic Development, Department of Immunotherapeutics and Biotechnology, Texas Tech University Health Sciences Center, 2Resonant Sensors Incorporated, 3University of Texas Arlington JoVE 52159 Immunology and Infection
